Top Industry Leaders in the Labyrinthitis Market
Medtronic acquires Sonitus Medical: December 2023 acquisition strengthens Medtronic's balance and gait portfolio, giving them access to Sonitus' vestibular rehabilitation technologies.
Vestibular Dynamics partners with Oticon: October 2023 collaboration combines Vestibular Dynamics' expertise in balance assessment with Oticon's hearing aid technology, aiming to develop integrated solutions for managing both vertigo and hearing loss associated with labyrinthitis.
Medtronic acquires Emblation Therapeutics: December 2023 deal strengthens Medtronic's position in the inner ear treatment landscape, potentially paving the way for new minimally invasive solutions for labyrinthitis.
Acteon collaborates with the University of California, San Diego: partnership focuses on developing advanced diagnostic tools for inner ear disorders, including labyrinthitis, potentially leading to earlier and more accurate diagnoses.
List of Labyrinthitis Key Companies in the Market
- Merck & Co.Inc.
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Eli Lilly and Company
- Sun Pharmaceutical Industries Ltd.
- Shandong Taihua Bio &Tech Co.
- Cipla Inc